- QbD vs Troubleshooting - A science-based approach to shorten tablets development time
- EScalate® Plasma Protein Binding Assay Service
- Establishment of a yeast-based VLP platform for antigen presentation
- ARTES White Paper outlines high-yield production process for secreted and active Invertase
- Laser diffraction: Safe migration from Malvern Mastersizer 2000 to Mastersizer 3000
- High level methanol-free phytase production in Pichia pastoris
- Orthotopic and metastasis models for preclinical efficacy testing of novel cancer drugs
- Problems in determining particle sizes during clinical development
- Drug efficacy evaluation in bone metastasis models
- Meta Stable Zone determination
- Optimizing development resources for efficient product development
- ICH Guidelines on particle properties
- Welcome to the World of Peptides
- Reducing development cost of pharmaceutical drugs through risk evaluation on particle and crystalline properties
- Mammalian Cell Culture
- Maltitol in taste masking of acetaminophen chewable tablets: synergy of combination with intense sweetener
- β-Cyclodextrins as a Solubilization Tool for Insoluble APIs
- Calorimetric Studies in Early Stage of Chemical Process Development
- Liquid Handling Engineering
- Optimising excipient properties for ODT formulation
- Quality Metrics: What Gets Measured, Gets Done
- Combination Products: A 40 Year Regulatory Evolution
- LLS - Liquid Level Sensing methods in qPCR set-up
- BioSiteHisto GLP-Laboratory offers services in histology, immunohistochemistry and in vitro research
- How antibodies are optimized into Optibodies
- Contamination Concerns
- Solid Phase Peptide Synthesis
- Dry granulation and its application in dietary supplements manufacturing
- New technologies for safe and contained powder handling in the bulk pharmaceutical industry
- Imazamox A Quest for Polymorphic Modifications of a Chiral and Racemic Herbicide
- Reaction Calorimetry
- SYSTAG’s vade mecum for thermoanalysis
- Water Engineering Plants
- Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist
- Tumor Development and Animal Welfare in a Murine Xenograft Model
- FDA Title 21 CFR Part 11 - Electronic Guidance
- Risk Mitigation Through Polymorphic Screening
- Survival Benefit With Radium-223 Dichloride in a Mouse Model of Breast Cancer Bone Metastasis
- Complete Solution for Cleanrooms and Controlled Environments
- Veterinary Vaccine Against Hepatitis E
- Therapeutic Peptides Alternative Drug Delivery Platforms
- Challenges for Therapeutic Peptides
- Hepatitis C Vaccine Research and Development
- Canicart®: Clinical Case Study for the Treatment of Osteoarthritis in the Adult Dog
- Bacteriophage Contamination
- HIV Neutralisation Assay
- API Solubility and Bioavailability
- cDNA Synthesis from mRNA
- Clinical Proof of Concept Studies in Cancer Drug Development
- Transient Transfected Cells
- Pharmacovigilance Services Report Writing
- Containment Rooms
- Drug Regulatory Affairs Services
- Optimizing Quality and Increasing Production Throughput with Automated Tablet Testing
- Outsourcing Pharmacovigilance Services
- CNS - Drug Development
- Key Factors Influencing Measured Tablet Hardness
- In Vitro Skin Irritation Test
- PepID BioPeptides
- SNP Markers Retrieval for a Non-model Species a Practical Approach
- Assessing Filling Technologies For Contamination Risk
- Wall Mounted Fog Shower
White Papers
